RSV recombinant protein vaccine (Changchun Baike)

呼吸道合胞病毒重组蛋白疫苗（长春百克）

Report date: 2022/04/18 15:04:03

Base Information

Drug NameRSV recombinant protein vaccine (Changchun Baike)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChangchun Bcht Biotechnology Co

China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A